苑东生物(688513)每日收评(06-27)

Group 1 - The stock of Yuandong Biotech (688513) has a comprehensive score of 51.09, indicating a strong performance [1] - The current main cost is 40.70 CNY, with a 5-day main cost of 39.96 CNY, a 20-day main cost of 41.49 CNY, and a 60-day main cost of 36.93 CNY [1][2] - The stock has not experienced any limit-up or limit-down events in the past year [1] Group 2 - The stock price has broken through the short-term resistance level, suggesting a potential short-term strength, while the mid-term trend remains unclear [2] - The net inflow of main funds on June 27, 2025, was 13.76 million CNY, accounting for 7% of the total transaction volume [2] - The financial data shows earnings per share of 0.34 CNY, operating profit of 0.62 billion CNY, and a sales gross margin of 79.155% [3][2] Group 3 - The stock is associated with several industry sectors, including chemical pharmaceuticals (0.94%), infant and child concepts (0.71%), monoclonal antibodies (0.72%), and immunotherapy (1.10%) [4]